Search

everythinglearnresearchcommunity

for

Search:↓

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Some drugs used to treat inflammation may cause hair loss.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Tislelizumab can cause cutaneous lupus erythematosus.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Monitoring for adverse effects in clinical treatments is crucial.

Tocilizumab might be an effective treatment for COVID-19.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

New therapies for rare skin diseases show promise but need more research.

Acitretin may cause salivary gland inflammation.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Skin conditions can signal heart issues, highlighting the need for integrated care.